Super-Dragon Engineering Plastics
301131
Broadex Technologies
300548
Zhejiang Zhaofeng Mechanical And Electronic
300695
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US Stock MarketDetailed Quotes
GRFS Grifols
- 7.150
- -0.060-0.83%
Close Apr 28 16:00 ET
4.86BMarket Cap27.19P/E (TTM)
7.310High7.140Low967.88KVolume7.290Open7.210Pre Close6.96MTurnover0.17%Turnover Ratio27.19P/E (Static)680.41MShares9.96052wk High0.83P/B4.01BFloat Cap5.79052wk Low--Dividend TTM560.96MShs Float24.966Historical High--Div YieldTTM2.36%Amplitude3.263Historical Low7.194Avg Price1Lot Size
About Grifols Company
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma Segment includes all activities related with products deriving from human plasma for therapeutic use. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
Company Profile
SymbolGRFS
Company NameGrifols
Listing DateJun 2, 2011
Founded1940
CEOMr. Jose Ignacio Abia Buenache
MarketNASDAQ
Employees23822
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressAvinguda de la Generalitat, 152-158,Parc de Negocis Can Sant Joan,Sant Cugat del Vallès
CityBarcelona
ProvinceCatalonia
CountrySpain
Zip Code08174
Phone34-93-571-02-21
Websitehttp://www.grifols.com
Company Executives
- Name
- Position
- Salary
- Jose Ignacio Abia Buenache
- Director and Chief Executive Officer
- --
- Montse Ribas
- Chief Communications and Reputation Officer
- --
- Rahul Srinivasan
- Chief Financial Officer
- --
- Jaime Gonzalez Peralta
- Chief Digital Information Officer
- --
- Enrique de la Torre
- Chief Compliance Officer
- --
- David Ian Bell
- General Counsel, Chief Corporate Affairs and Legal Officer
- --
- Daniel Fleta Coit
- Chief Industrial Services Officer
- --
- Camille Alpi
- Chief Human Resources and Talent Officer
- --
- Dr. Jorg Schuttrumpf
- Chief Scientific Innovation Officer
- --
- Ignacio Ramal Subira
- Chief Internal Audit and Enterprise Risk Manager
- --
- Lluis Pons Gomez
- Senior Vice President, Strategy
- --
- Thomas H. Glanzmann
- Executive Chairman of the Board
- --
- Raimon Grifols Roura
- Vice Chairman of the Board
- 58.33K
- Jordi Balsells Valls
- President, Plasma Procurement
- --
- Dr. Roland Wandeler, PhD
- President, Biopharma Business Unit
- --
- Dr. Antonio Martinez Martinez
- President, Diagnostic
- --
- Víctor Grifols Deu
- Director
- 58.33K
- Tomas Daga Gelabert
- Director
- --
- Paul S. Herendeen
- Director
- 6.30K
- Albert Grifols Coma-Cros
- Director
- 100.00K
- Susana Gonzalez Rodriguez
- Independent Director
- 125.00K
- Montserrat Munoz Abellana
- Lead Independent Director
- 150.00K
- Enriqueta Felip Font
- Independent Director
- 125.00K
- Anne-Catherine Berner
- Independent Director
- 75.00K
- Pascal Ravery
- Independent Director
- 6.30K
- Inigo Sanchez-Asiain Mardones
- Independent Director
- 150.00K
- Nuria Martin Barnes
- Secretary
- --
- Laura de la Cruz Galan
- Vice Secretary
- --
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀